Lysyl Enzymes in Knee Osteoarthritis
Official title: Lysyl Oxidase and Lysyl Hydroxylase Levels in Patients With Knee Osteoarthritis
Run by Afyonkarahisar Health Sciences University · NCT07875296 · Data updated 2026-11-12
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 70 Years |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Afyonkarahisar Health Sciences University Academic / other |
| Locations | 1 site (Afyonkarahisar) |
| Status | Recruiting |
| Started | May 5, 2025 |
| Main results expected | January 3, 2027 |
| Study ends | April 3, 2027 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07875296 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 40–70 with clinically and radiographically diagnosed knee OA, within BMI 18.5–40 kg/m², without major comorbidities.
✕Probably not a fit
Patients with significant comorbidities or non-OA knee conditions may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will measure serum levels of lysyl hydroxylase, lysyl oxidase, and related LOX family enzymes in adults with knee OA at different stages and compare them to healthy controls. It will focus on how these enzymes relate to joint degeneration and ECM cross-linking in the cartilage. Participants are female, 40–70 years old, with knee OA, recruited from Afyonkarahisar Health Sciences University, with BMI 18.5–40 kg/m². The study will exclude those with major comorbidities or inflammatory rheumatic diseases. No interventions are administered; samples and data are collected to explore potential biomarkers and disease mechanisms.
Why it matters
Potential benefit: If successful, findings could identify biomarkers that reflect cartilage remodeling and disease progression in knee OA.
How similar studies have gone: Similar work has begun to explore LOX family enzymes in OA, but this study adds a focused biomarker comparison with healthy controls.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female participants aged between 40 and 70 years. * Diagnosed with knee osteoarthritis according to clinical and radiographic criteria, and presenting to the Department of Physical Medicine and Rehabilitation, Afyonkarahisar Health Sciences University (AFSU). * Body Mass Index (BMI) between 18.5 and 40 kg/m². Exclusion Criteria: * Presence of metabolic diseases or severe comorbidities, including uncontrolled diabetes mellitus, chronic kidney disease (GFR \< 60 mL/min/1.73 m²), liver failure, malignancy, severe cardiovascular disease, chronic respiratory disorders, or chronic intestinal diseases. * Any inflammatory arthritis or other rheumatologic disease with related signs or symptoms. * History of knee trauma involving cruciate ligaments or menisci within the past 3 months. * Secondary osteoarthritis due to other joint disorders such as septic arthritis, avascular necrosis, or Paget's disease. * History of previous knee surgery. * Recent intra-articular injection to the knee joint within the last 3 months.
Where it's running
-
Afyonkarahisar Health Sciences University, Department of Physical Medicine and Rehabilitation
Afyonkarahisar, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Hasan Toktaş, Professor — Afyonkarahisar Health Sciences University
- Study coordinator: Hasan Toktaş, Professor
- Email: hasantoktas@yahoo.com
- Phone: +905052212901
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Differences in Functional Capacity in Knee Osteoarthritis with Similar Pain
This study tests factors that might explain why people with knee osteoarthritis and similar pain levels have different abilities to walk, stand, and perform daily tasks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.